SEC Form 4 · accession 0001179110-17-011766
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard S Levy
Director
Period of report
Aug 22, 2017
Accepted (ET)
Aug 23, 2017 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 22, 2017 | P | 90 | $15.99 | A | 3,640 | D | |
| Common Stock | Aug 22, 2017 | P | 389 | $16.10 | A | 4,029 | D | |
| Common Stock | Aug 22, 2017 | P | 2,944 | $16.12 | A | 6,973 | D | |
| Common Stock | Aug 22, 2017 | P | 127 | $16.14 | A | 7,100 | D |
Table II — derivative securities
No Table II lines on this filing.